Success rates soared to 75% for patients who waited less than two years for a spinal cord stimulator implant, compared with 15% for patients whose who received implants 20 years after the onset of pain, according to a retrospective analysis. The length of time patients waited for a referral also varied by specialty, as shown in a scientific poster presented at the 30th Annual Meeting of the American Academy of Pain Medicine.
Lpath, according to a company release, has brought scientists one step closer to finding a potential treatment for traumatic brain injury with a recent publication showing that Lpathomab, an anti-lysophosphatidic acid antibody, reverses much of the damage caused by trauma to the nervous system.
One of the most devastating symptoms of stroke is motor deficit. It is widely believed that if there is no improvement after one year of intensive physiotherapy, the symptoms will persist for life. Now, new therapies are being developed to directly stimulate the damaged brain after a stroke in order to promote additional healing beyond that achieved by conventional physiotherapy.
A direct aspiration first pass technique (ADAPT) with a large bore aspiration catheter has been shown to be “fast, safe, simple and effective method” for acute ischaemic stroke thrombectomy. The results were published in the Journal of of NeuroInterventional Surgery.
In a study conducted by William Mehan et al, it was found that for patients with unruptured intracranial aneurysms, multilobulated morphology and interval growth of the unruptured aneurysms are “characteristics predictive of a higher risk of subsequent rupture during conservative CT angiography (CTA) follow-up.”
Avanir Pharmaceuticals announced the presentation of results from a first-of-its-kind study of pseudobulbar affect (PBA) symptoms in veterans with mild traumatic brain injury conducted in collaboration with the Department of Veterans Affairs and Evidera. The study will be presented at the Tenth World Congress on Brain Injury in San Francisco, USA, on Friday 21 March 2014.
A new paper published by a joint US and Canadian team in PLOS One suggests SPECT (single photon emission computed tomography)—a functional brain imaging modality that produces images of blood flow to the brain, showing areas of over or under-activity—is useful in both identifying and guiding treatment for those with traumatic brain injuries.
InspireMD announced that it has successfully enrolled the first patient in the CARENET (Carotid embolic protection study using MicroNet) multicentre European clinical trial for the new CGuard carotid embolic protection system.
A study reported in the International Headache Society’s official journal Cephalalgia found that the use of electroCore’s non-invasive vagus nerve stimulation therapy may be an effective and well tolerated treatment for migraine in certain patients.
Every 15-minute delay in delivering a clot-busting drug after stroke robs survivors of about a month of disability-free life, according to a new study in the American Heart Association journal Stroke.
Published in the Journal of NeuroInterventional Surgery, the results of a small study of 11 patients has demonstrated that Silk flow diverter stents (Balt Extrusion) could be a safe and feasible treatment for fragile, difficult-to-treat blood blister-like aneurysms.
Reverse Medical has announced receiving CE mark approval for the Barrel vascular reconstruction device and its first use in a European clinical case. The Barrel vascular reconstruction device is intended for use with occlusive devices in the treatment of intracranial aneurysms.
A new study published in Stroke has identified that there is a higher risk of stroke in people with high levels of anxiety.
Scientists at the University of Kansas School of Medicine and Case Western Reserve University have developed a lightweight, battery-powered device that appears capable of repairing damaged pathways in the brain. The technology holds promise helping individuals who suffer from the damage left by stroke or head injuries.
New retrospective data highlighting the Precision Spectra Spinal Cord Stimulator (Boston Scientific) System demonstrate the device provided highly significant pain relief three months after implantation. The results were presented at the North American Neuromodulation Society (NANS) 17th annual meeting in Las Vegas, USA (5–8 December).
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos